Li S, Tian T, Zhang T, Lin Y, Cai X
Nat Protoc. 2024; 20(2):336-362.
PMID: 39215132
DOI: 10.1038/s41596-024-01050-7.
Przybyszewski O, Mik M, Nowicki M, Kusinski M, Mikolajczyk-Solinska M, Sliwinska A
Biomedicines. 2024; 12(8).
PMID: 39200178
PMC: 11351910.
DOI: 10.3390/biomedicines12081713.
Khalaji A, Mehrtabar S, Jabraeilipour A, Doustar N, Rahmani Youshanlouei H, Tahavvori A
Ther Adv Cardiovasc Dis. 2024; 18:17539447241253134.
PMID: 38819836
PMC: 11143841.
DOI: 10.1177/17539447241253134.
Miskiewicz J, Mielczarek-Palacz A, Gola J
Biomedicines. 2023; 11(6).
PMID: 37371799
PMC: 10296063.
DOI: 10.3390/biomedicines11061704.
Wang Y, Malik S, Suh H, Xiao Y, Deng Y, Fan R
Sci Adv. 2023; 9(6):eabq7459.
PMID: 36753549
PMC: 9908025.
DOI: 10.1126/sciadv.abq7459.
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
Mortoglou M, Miralles F, Arisan E, Dart A, Jurcevic S, Lange S
Int J Mol Sci. 2022; 23(3).
PMID: 35163198
PMC: 8835847.
DOI: 10.3390/ijms23031275.
MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8.
Shen P, Sun G, Zhao P, Dai J, Zhang X, Zhao J
Transl Cancer Res. 2022; 9(5):3507-3517.
PMID: 35117716
PMC: 8799044.
DOI: 10.21037/tcr.2020.03.70.
MicroRNA-133b expression inversely correlates with MET and can serve as an optimum predictive biomarker for patients of colorectal cancer.
Xie B, Gong N, Guo Y, Hu G
Transl Cancer Res. 2022; 10(1):57-64.
PMID: 35116239
PMC: 8797913.
DOI: 10.21037/tcr-20-2370.
Methylation of and as a Biomarker for the Detection of Lung Cancer.
Szczyrek M, Grenda A, Kuznar-Kaminska B, Krawczyk P, Sawicki M, Batura-Gabryel H
Cancers (Basel). 2021; 13(23).
PMID: 34885248
PMC: 8657200.
DOI: 10.3390/cancers13236139.
Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy.
Mortoglou M, Tabin Z, Arisan E, Kocher H, Uysal-Onganer P
Transl Oncol. 2021; 14(7):101090.
PMID: 33831655
PMC: 8042452.
DOI: 10.1016/j.tranon.2021.101090.
NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells.
Garrido M, Torres I, Avila A, Chnaiderman J, Valenzuela-Valderrama M, Aramburo J
Int J Mol Sci. 2020; 21(20).
PMID: 33081171
PMC: 7589588.
DOI: 10.3390/ijms21207657.
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
Malik S, Lim J, Slack F, Braddock D, Bahal R
J Control Release. 2020; 327:406-419.
PMID: 32835710
PMC: 7606596.
DOI: 10.1016/j.jconrel.2020.08.026.
LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q, Cheng S, Cao L, Yang J, Wang Y, Chen Y
Biosci Rep. 2020; 40(3).
PMID: 32077915
PMC: 7064789.
DOI: 10.1042/BSR20192790.
Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.
Chen L, Wang G, Qiao X, Wang X, Liu J, Niu X
Med Sci Monit. 2020; 26:e921863.
PMID: 31990904
PMC: 6998793.
DOI: 10.12659/MSM.921863.
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.
Yang B, Sun L, Liang L
J Ovarian Res. 2019; 12(1):100.
PMID: 31640760
PMC: 6806521.
DOI: 10.1186/s13048-019-0576-3.
HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer.
Li H, Chi X, Li R, Ouyang J, Chen Y
Int J Biol Sci. 2019; 15(11):2438-2447.
PMID: 31595161
PMC: 6775309.
DOI: 10.7150/ijbs.38146.
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Rawat M, Kadian K, Gupta Y, Kumar A, Chain P, Kovbasnjuk O
Genes (Basel). 2019; 10(10).
PMID: 31557962
PMC: 6827136.
DOI: 10.3390/genes10100752.
MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
Shi D, Wang H, Ding M, Yang M, Li C, Yang W
Onco Targets Ther. 2019; 12:6605-6616.
PMID: 31496749
PMC: 6701645.
DOI: 10.2147/OTT.S205994.
In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma.
Hu S, Liao Y, Zheng J, Gou L, Regmi A, Zafar M
Biomed Res Int. 2019; 2019:2725192.
PMID: 31032340
PMC: 6458921.
DOI: 10.1155/2019/2725192.
Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro.
Malik S, Bahal R
J Nanobiotechnology. 2019; 17(1):57.
PMID: 31010426
PMC: 6475967.
DOI: 10.1186/s12951-019-0490-2.